Pradelli L, Ascierto P. [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. FE [Internet]. 2017 Sep. 21 [cited 2025 Jul. 23];18(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1329